170 related articles for article (PubMed ID: 34055091)
1. Prognostic and immunological roles of Fc fragment of IgG binding protein in colorectal cancer.
Zhuang Q; Shen A; Liu L; Wu M; Shen Z; Liu H; Cheng Y; Lin X; Wu X; Lin W; Li J; Han Y; Chen X; Chen Q; Peng J
Oncol Lett; 2021 Jul; 22(1):526. PubMed ID: 34055091
[TBL] [Abstract][Full Text] [Related]
2. FCGBP Is a Prognostic Biomarker and Associated With Immune Infiltration in Glioma.
Yan T; Tian D; Chen J; Tan Y; Cheng Y; Ye L; Deng G; Liu B; Yuan F; Zhang S; Cai L; Chen Q
Front Oncol; 2021; 11():769033. PubMed ID: 35047393
[TBL] [Abstract][Full Text] [Related]
3. IgG Fc Binding Protein (
Yuan Z; Zhao Z; Hu H; Zhu Y; Zhang W; Tang Q; Huang R; Gao F; Zou C; Wang G; Wang X
Onco Targets Ther; 2021; 14():967-977. PubMed ID: 33603401
[TBL] [Abstract][Full Text] [Related]
4. A bioinformatic analysis: the overexpression and clinical significance of FCGBP in ovarian cancer.
Wang K; Guan C; Shang X; Ying X; Mei S; Zhu H; Xia L; Chai Z
Aging (Albany NY); 2021 Mar; 13(5):7416-7429. PubMed ID: 33686968
[TBL] [Abstract][Full Text] [Related]
5. [IgG Fc binding protein (FCGBP) as a prognostic marker of low-grade glioma and its correlation analysis with immune infiltration].
Liu Q; Zhang J; Zhang F; Zhang W; Gong L
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2023 Aug; 39(8):686-692. PubMed ID: 37515334
[TBL] [Abstract][Full Text] [Related]
6. Fc fragment of IgG binding protein is correlated with immune infiltration levels in hepatocellular carcinoma.
Suo Y; Hou C; Yang G; Yuan H; Zhao L; Wang Y; Zhang N; Zhang X; Lu W
Biomol Biomed; 2023 Jul; 23(4):605-615. PubMed ID: 36803544
[TBL] [Abstract][Full Text] [Related]
7. Multi-Omics Analyses to Identify FCGBP as a Potential Predictor in Head and Neck Squamous Cell Carcinoma.
Lin YH; Yang YF; Shiue YL
Diagnostics (Basel); 2022 May; 12(5):. PubMed ID: 35626334
[TBL] [Abstract][Full Text] [Related]
8. A Novel Prognostic Marker and Therapeutic Target Associated with Glioma Progression in a Tumor Immune Microenvironment.
Zhang JJ; Zhang Y; Chen Q; Chen QN; Yang X; Zhu XL; Hao CY; Duan HB
J Inflamm Res; 2023; 16():895-916. PubMed ID: 36883185
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the Prognostic Relevance of Differential Claudin Gene Expression Highlights Claudin-4 as Being Suppressed by TGFβ1 Inhibitor in Colorectal Cancer.
Yang L; Zhang W; Li M; Dam J; Huang K; Wang Y; Qiu Z; Sun T; Chen P; Zhang Z; Zhang W
Front Genet; 2022; 13():783016. PubMed ID: 35281827
[No Abstract] [Full Text] [Related]
10. Identification of Cysteine Protease Inhibitor CST2 as a Potential Biomarker for Colorectal Cancer.
Xie Q; Liu L; Chen X; Cheng Y; Li J; Zhang X; Xu N; Han Y; Liu H; Wei L; Peng J; Shen A
J Cancer; 2021; 12(17):5144-5152. PubMed ID: 34335931
[TBL] [Abstract][Full Text] [Related]
11. Integrating proteomics and transcriptomics for the identification of potential targets in early colorectal cancer.
Yang W; Shi J; Zhou Y; Liu T; Zhan F; Zhang K; Liu N
Int J Oncol; 2019 Aug; 55(2):439-450. PubMed ID: 31268166
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive Analysis of Prognostic Value and Immune Infiltration of Chromobox Family Members in Colorectal Cancer.
Li Q; Pan Y; Cao Z; Zhao S
Front Oncol; 2020; 10():582667. PubMed ID: 33014884
[No Abstract] [Full Text] [Related]
13. Overexpression of LBX2 associated with tumor progression and poor prognosis in colorectal cancer.
Huang X; Yang Y; Yang C; Li H; Cheng H; Zheng Y
Oncol Lett; 2020 Jun; 19(6):3751-3760. PubMed ID: 32382328
[TBL] [Abstract][Full Text] [Related]
14. Identification of metastasis-associated genes in colorectal cancer using metaDE and survival analysis.
Qi C; Hong L; Cheng Z; Yin Q
Oncol Lett; 2016 Jan; 11(1):568-574. PubMed ID: 26870249
[TBL] [Abstract][Full Text] [Related]
15. Down-regulated Solute Carrier Family 4 Member 4 Predicts Poor Progression in Colorectal Cancer.
Yang H; Lu Y; Lan W; Huang B; Lin J
J Cancer; 2020; 11(12):3675-3684. PubMed ID: 32284764
[No Abstract] [Full Text] [Related]
16. Comprehensive analysis of the prognostic and immunotherapeutic implications of STAT family members in human colorectal cancer.
Li D; Jiao Y; Gao W; Hu S; Li D; Zhao W; Chen P; Jin L; Zhao Y; Ma Z; Wu X; Yan Y; Sun W; Du X; Dong G
Front Genet; 2022; 13():951252. PubMed ID: 36061181
[No Abstract] [Full Text] [Related]
17. Potential of six-transmembrane epithelial antigen of the prostate 4 as a prognostic marker for colorectal cancer.
Fang ZX; Li CL; Chen WJ; Wu HT; Liu J
World J Gastrointest Oncol; 2022 Sep; 14(9):1675-1688. PubMed ID: 36187390
[TBL] [Abstract][Full Text] [Related]
18. Karyopherin alpha 2 expression is a novel diagnostic and prognostic factor for colorectal cancer.
Yu L; Wang G; Zhang Q; Gao L; Huang R; Chen Y; Tang Q; Liu J; Liu C; Wang H; Wang X
Oncol Lett; 2017 Mar; 13(3):1194-1200. PubMed ID: 28454233
[TBL] [Abstract][Full Text] [Related]
19. Abnormal expression of ABCD3 is an independent prognostic factor for colorectal cancer.
Zhang Y; Zhang Y; Wang J; Yang J; Yang G
Oncol Lett; 2020 May; 19(5):3567-3577. PubMed ID: 32269631
[TBL] [Abstract][Full Text] [Related]
20. Integrated bioinformatics analysis revealing independent prognostic long non-coding RNAs DNAH17-AS1 and RP11-400N13.2 and their potential oncogenic roles in colorectal cancer.
Zhou W; Pan B; Liu L
Oncol Lett; 2019 Oct; 18(4):3705-3715. PubMed ID: 31516583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
